Driven by the dual benefits of US-regulated futures launches and buy-back mechanisms, institutional demand for INJ is rapidly being unleashed. Compliant trading data lays the foundation for potential spot ETF applications. In the short term, the price has effectively stabilized above $3.20, with clear bullish momentum. If trading volume continues to increase, $3.41 becomes a resistance level for further upward movement, while support for pullbacks should be watched in the $3.20~$3.30 range. It is recommended to focus on liquidity and compliance progress for medium-term positioning, maintain high-sell/low-buy strategies within the range for short-term trades, and emphasize supply contraction and structural opportunities under the ETF theme for long-term investment.

Recently, the first monthly contracts launched under CFTC regulation, denominated in INJ and allowing USD or digital assets as collateral, have provided institutional clients with a channel to gain price exposure without holding the token. The accompanying open-interest fee surged 20% week-on-week, indicating rapidly unleashed demand for derivatives strategies among institutions. These contract records will contribute to six months of trading data, further consolidating INJ’s compliant status in the US market and providing substantial support for potential spot ETF applications.

Bitnomial has launched Injective monthly futures contracts on its Chicago-based crypto derivatives exchange, marking Injective's first entry into the US regulated derivatives market. Settled in INJ and expiring monthly, these futures allow traders price exposure without holding the underlying asset, using crypto or USD as margin. Institutional clients can trade immediately, with retail access coming soon. The move is expected to build a six-month trading record supporting spot ETF applications.

Bitnomial launches Injective futures in the US, potentially supporting eligibility for spot ETF applications.

Following the news, INJ price witnessed a rapid surge, breaking through $3.30 in a single day with gains exceeding 10%, accompanied by a significant increase in trading volume. Daily candlesticks show a bullish breakout has activated momentum, and with yesterday’s closing price at $3.38, the $3.20 support for bulls has been validated. If volume continues to rise in the short term, bulls may further test the $3.41 resistance; in the event of a pullback, renewed buying is expected in the $3.30~$3.20 range.

Injective (INJ) surged over 10% to above $3.30 following the launch of US-regulated futures contracts on Bitnomial, a CFTC-regulated exchange. This development positions INJ alongside major cryptocurrencies with regulated futures, enabling institutional participation without direct token holding. The move has increased trading volume and momentum, with key support at $3.20 and resistance at $3.41, signaling potential for further gains.

Why is Injective (INJ) surging 10% after US futures launch?

This month, INJ completed a buy-back of 51,000 tokens, up 4% from the previous month, creating tangible scarcity on the supply side and increasing market recognition of protocol value. The buy-back cost is at recent average price levels, providing solid support for secondary market bids, helping stabilize price fluctuations and counteract short-term sell pressure.

Injective completed this month's INJ token buyback, repurchasing 51,000 INJ tokens valued at approximately $156,000, marking a 4% increase compared to March.

Injective completes this month's INJ token buyback, valued at approximately $156,000.

Combined with accumulating compliant futures trading records and the dual benefits of supply reduction and buy-backs, INJ has gathered core conditions at the fundamental level for a spot ETF. Technically, the daily chart shows consolidation and upward movement from the $3.20 zone, maintaining the medium-term ascending channel. It is recommended to monitor future exchange compliance upgrades and liquidity growth for medium- to long-term investment opportunities.

Injective

BoE: MPC Maintains a Cautious Stance – Rabobank

Euro-zone inflation probably jumped in April to the highest in 2 1/2 years as fallout from the Iran war squeezed economies across the currency area

USD/JPY: Supported but capped below 160 – DBS

The U.S. Attorney for Washington, D.C.: Will stop the investigation into Powell's Federal Reserve building costs.

The final value of the one-year inflation rate expectation in the US for April is 4.7%.

Bank of Canada to hold interest rates this year, show patience with energy inflation: Reuters poll

ECB: Rate hike call pushed to June – Rabobank

Economists raised their estimates for US inflation and said they expect only one Federal Reserve interest-rate cut this year amid elevated energy costs sparked by the Iran war.

The central bank and eight other departments: Prohibit providing online marketing services for virtual currency issuance and trading.

USD: Cautious tone into weekend – ING

Bybit-eu

Live chart for Injective to USD conversion. Check out INJ to USD prices in real time. Convert, buy, sell, and trade Injective on Bybit-eu.

Injective Price: INJ Live Price Today | INJ Market Cap & Chart Analysis | Bybit-eu

current_price

price_change_24h

high_24h

low_24h

volume_24h

market_cap

circulating_supply

ath_price

atl_price

INJ price today is 3.44, with a live price change of 3.59 in the last 24 hours. Convert, buy, sell and trade INJ on Bybit-eu.

Track Injective live price, market cap, 24-hour trading range, and real-time chart data on Bybit-eu.

Injective Τιμή

Στατιστικά στοιχεία Τιμών

Injective Ειδήσεις

Ιστορικό τιμών (USD)

Injective Πόροι

Injective Τιμή

Στατιστικά στοιχεία Τιμών

Injective Ειδήσεις

Ιστορικό τιμών (USD)

Injective Πόροι

Σάρωση για λήψη εφαρμογής

Ακολούθησέ μας στα μέσα κοινωνικής δικτύωσης